Global viral inactivation market to expand at a healthy 7.4% CAGR from 2017 to 2025 to become worth US$5.736 bn by 2025 from US$3.05 bn in 2016.
Albany, NY -- (SBWIRE) -- 10/13/2017 -- There are some products that can be harmed by the presence of viral particles hence certain techniques are used widely in the food and blood plasma industries to make virus ineffective though its presence is still there. A detailed research report titled "Viral Inactivation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025" has recently been added into the database of "Market Research Hub (MRH)" that completely focuses on global viral inactivation market, analyzing its trends, growth and estimating future of the market with numbers.
Request Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1339670
In viral inactivation, the viruses may remain in the final product, but in a non-infective form. The common viruses removed by such methods are hepatitis A, B, and C; HIV-1 and HIV-2 viruses; and parvoviruses. The study for viral clearance is extremely important for commercialization of biopharmaceutical products, manufacturing and clinical trials. The products that are developed from animal resources, plants and human such as biologics are known to carry number of pathogenic and human viruses and are expected to have high risk of viral contamination.
The study report discusses the market dynamics and analyses drivers, restraints in the market of viral inactivation globally. According to the report, the drivers in the viral inactivation market are fast growth of biologics market and biosimilars in the sector of biopharmaceutical, the increase in approval for new drugs, regulatory compliances of biologics products for viral inactivation.
According to the report, out of total 51 drugs approved during 2015, 45 drugs were approved by Center for Drug Evaluation and Research and 6 drugs were approved by Center for Biologics Evaluation and Research. Additionally, in March 2015, the first biosimilars product for marketing in the US was approved by US FDA. Since then it says, there was increase in filing large number of biosimilars products for FDA clearance and more of new applications are still expected during forecast period 2017 to 2025.
The report estimates more than US$ 100 Bn biologics products market to go off patent in the next few years and which will then allow entry for biosimilars products market. This anticipated growth in biosimilars market is predictable to be a major driving factor for global viral inactivation market. With this, it also states that the growth of viral inactivation market will limit due to the high cost of development and manufacturing of biologics, biosimilars products and equipment.
Browse Full Report with TOC- https://www.marketresearchhub.com/report/viral-inactivation-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
The report has segmented the global viral inactivation market into four segments as region, end user, application and methods used. Basis method, the viral inactivation market is divided into radiation, chemical and other methods used for viral inactivation. The chemical method dominates the market of viral inactivation as it is one of the most efficient, economical and safer methods. The chemical method is divided as pH concentration method, use of alkylating agent method and solvent detergent method. It is anticipated that the solvent detergent method will account for the maximum market share through 2025. The report also predicts that the radiation method can witness highest CAGR due to increase in adoption by most of blood center in emerging countries.
Further the report has segmented application wise segment into vaccines, cell and tissue culture products and blood & blood products. The end user includes contract research organizations, the pharmaceutical and biotechnology companies, blood banks & hospitals and other end users in the market of viral inactivation.
Geographically, the global viral inactivation market is segmented into five regions as Latin America, Middle East & Africa, Europe, North America and Asia Pacific.
Enquire about this Report- https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1339670
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,
Toll Free : 800-998-4852 (US-Canada)
Email : firstname.lastname@example.org
Website : https://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/